<DOC>
	<DOCNO>NCT01310400</DOCNO>
	<brief_summary>A study ass whether Northern Hemisphere 2009/2010 season influenza vaccine Inflexal V immunogenic locally sourced competitor vaccine young child .</brief_summary>
	<brief_title>Comparison Efficacy Inflexal V With Commercially Available Influenza Vaccine Young Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>≥6months ≤35 monthsold healthy child ( male female ) born term normal pregnancy Recording medical history physical examination reveal abnormality The parent/legal guardian participate child must sign write informed consent agree provide blood sample take child pre postimmunization Exclusion criterion : Hypersensitivity egg , chicken protein , polymyxin B , neomycin component vaccine Previous vaccination influenza At time enrollment , presentation clinical symptom active infection and/or body temperature ≥38°C Confirmation suspicion immunosuppressed status ( include cancer ) , confirmation immunodeficiency disease ( congenital acquire include HIV ) Medical treatment ( &gt; 2 week ) immune suppressant immune modulate drug include systemic steroid last 3 month immunization present , follow : longterm oral prednisone equivalent steroid : ≥0.5mg/kg/day ( note : administration local inhale steroid study allow ) Treatment immunoglobulins blood product last 3 month immunization treatment schedule study Participation clinical trial last 3 month immunization intention participate study period At present last 6 month immunization : radiotherapy treatment cytotoxic drug Other vaccination kill vaccine within 14 day immunization attenuate vaccine within 28 day immunization ( note : subject inclusion vaccine immunization program child allow upon physician 's discretion . However , immunization day must avoid ) Family history GuillainBarré Syndrome Severe congenital deficiency disease Antecedent neurological disease epileptic attack Severe cardiopulmonary disease possibility influence study result Disturbance coagulation anticoagulant treatment , likely contraindicate i.m . injection Suspected noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Virus</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Immunisation</keyword>
</DOC>